Tonix Pharmaceuticals Holding Corp. (TNXP) is a publicly traded Healthcare sector company. As of May 21, 2026, TNXP trades at $14.21 with a market cap of $227.32M and a P/E ratio of -0.99. TNXP moved +5.47% today. Year to date, TNXP is -4.73%; over the trailing twelve months it is -51.51%. Its 52-week range spans $6.76 to $130.00. Analyst consensus is strong buy with an average price target of $41.33. Rallies surfaces TNXP's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Which politicians traded TNXP stock?
Rallies tracks politician and congressional stock disclosures for TNXP, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
Rallies tracks politician and congressional stock disclosures for TNXP, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
Does Rallies track congressional trades in TNXP?
Yes. Rallies tracks politician and congressional stock disclosures for TNXP, including reported purchases, sales, dates, owners, and trade amounts when available.
Is TNXP research on Rallies investment advice?
No. Rallies provides research, data, and educational context for TNXP. It does not provide personalized investment advice.
